Novartis AG and Astellas Pharma eczema drugs may have to expand their warning labels after dozens of new reported cases of cancer and infection in children, according to the U.S. Food and Drug Administration. On March 18th, scientists with the FDA said 46 cancer cases and 71 infection cases have been reported in patients aged 16 and younger from 2004 to 2008. Elidel is made by Novartis and Protopic is made by Astellas. Both drugs — also known as pimecrolimus and tacrolimus respectively — already carry strong warnings about cancer and infection, but officials should now consider expanding them to include the new post-marketing reports, according to the FDA.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.